Nanalysis Scientific Corp.
NSCIF
$0.2215
$0.01175.58%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 47.73% | 61.94% | 139.58% | 35.74% | -0.49% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 47.73% | 61.94% | 139.58% | 35.74% | -0.49% |
| Cost of Revenue | 35.90% | 30.57% | 87.19% | 34.55% | 31.20% |
| Gross Profit | 89.53% | 323.10% | 5,129.68% | 41.62% | -46.30% |
| SG&A Expenses | -8.17% | -7.94% | -19.03% | -31.05% | -14.71% |
| Depreciation & Amortization | 0.63% | -6.65% | -5.19% | -14.87% | -4.24% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.92% | 14.11% | 33.63% | 3.18% | 5.19% |
| Operating Income | 63.14% | 72.83% | 65.68% | 52.40% | -23.50% |
| Income Before Tax | 74.82% | 55.01% | 48.32% | 71.50% | -163.12% |
| Income Tax Expenses | 102.44% | 98.11% | 101.43% | 239.56% | -151.16% |
| Earnings from Continuing Operations | 74.28% | 51.69% | 41.43% | 35.66% | -135.31% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -100.00% | -- |
| Net Income | 74.28% | 48.88% | 36.03% | 26.71% | -148.10% |
| EBIT | 63.14% | 72.83% | 65.68% | 52.40% | -23.50% |
| EBITDA | 52.92% | 69.88% | 61.40% | 50.30% | -48.60% |
| EPS Basic | 76.84% | 55.05% | 41.42% | 31.86% | -129.85% |
| Normalized Basic EPS | 57.52% | 57.80% | 49.76% | 39.64% | -47.12% |
| EPS Diluted | 68.18% | 51.01% | 41.42% | 31.86% | -100.87% |
| Normalized Diluted EPS | 57.52% | 57.80% | 49.76% | 39.64% | -47.12% |
| Average Basic Shares Outstanding | 11.51% | 13.94% | 9.26% | 7.66% | 7.65% |
| Average Diluted Shares Outstanding | 11.51% | 13.94% | 9.26% | 7.66% | 7.65% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |